Autonomix medical, inc. reports third quarter fiscal year 2025 financial results and provides a corporate update

Ongoing proof-of-concept (poc) clinical trial in pain associated with pancreatic cancer with topline data on track for 1h 2025

AMIX Ratings Summary

AMIX Quant Ranking